MHRA approves catumaxomab for malignant ascites in adults – Atnahs Pharma UK Limited
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved catumaxomab (Korjuny) to treat malignant ascites in adults when standard treatment of their cancer is no longer feasible…. read more.
